Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thilo von Groote

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Frontiers in Immunology|October 31, 2022
Increased prevalence of clonal hematopoiesis of indeterminate potential in hospitalized patients with COVID-19Judith Schenz, Katharina Rump, Benedikt Hermann Siegler, et al.
Critical Care (London, England)|September 2, 2025
Plasma proteomics identifies molecular subtypes in sepsisThilo Bracht, Kerstin Kappler, Malte Bayer, et al.
Frontiers in Immunology|May 23, 2024
Exploring the relationship between HCMV serostatus and outcomes in COVID-19 sepsisDominik Ziehe, Alexander Wolf, Tim Rahmel, et al.
Intensive Care Medicine|June 30, 2026
Effects of a clinical metagenomics intervention on clinical outcomes, healthcare costs, and health-related quality of life in patients with sepsis or septic shock: results of the randomized-controlled DigiSep trialThorsten Brenner, Annabell Skarabis, Stefan J Schaller, et al.
BMJ Open|September 22, 2025
Randomised controlled study investigating standard dose continuous renal replacement therapy (CRRT) versus low-dose CRRT in critically ill patients with acute kidney injury (AKI): study protocol for a prospective, randomised, controlled, international, multicentre trial (the 'Ketzerei' trial)Christian Strauß, Mahan Sadjadi, Thilo von Groote, et al.
Critical Care Medicine|March 28, 2023
The Role of Cell Cycle Arrest Biomarkers for Predicting Acute Kidney Injury in Critically Ill COVID-19 Patients: A Multicenter, Observational StudyRaphael Weiss, Thilo von Groote, Marlies Ostermann, et al.
Lancet (London, England)|November 16, 2025
A preventive care strategy to reduce moderate or severe acute kidney injury after major surgery (BigpAK-2); a multinational, randomised clinical trialAlexander Zarbock, Marlies Ostermann, Lui Forni, et al.
BMJ Open|March 27, 2023
Biomarker-guided intervention to prevent acute kidney injury after major surgery (BigpAK-2 trial): study protocol for an international, prospective, randomised controlled multicentre trialThilo von Groote, Melanie Meersch, Stefano Romagnoli, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Frontiers in Immunology|October 31, 2022
Increased prevalence of clonal hematopoiesis of indeterminate potential in hospitalized patients with COVID-19Judith Schenz, Katharina Rump, Benedikt Hermann Siegler, et al.
Critical Care (London, England)|September 2, 2025
Plasma proteomics identifies molecular subtypes in sepsisThilo Bracht, Kerstin Kappler, Malte Bayer, et al.
Frontiers in Immunology|May 23, 2024
Exploring the relationship between HCMV serostatus and outcomes in COVID-19 sepsisDominik Ziehe, Alexander Wolf, Tim Rahmel, et al.
Intensive Care Medicine|June 30, 2026
Effects of a clinical metagenomics intervention on clinical outcomes, healthcare costs, and health-related quality of life in patients with sepsis or septic shock: results of the randomized-controlled DigiSep trialThorsten Brenner, Annabell Skarabis, Stefan J Schaller, et al.
BMJ Open|September 22, 2025
Randomised controlled study investigating standard dose continuous renal replacement therapy (CRRT) versus low-dose CRRT in critically ill patients with acute kidney injury (AKI): study protocol for a prospective, randomised, controlled, international, multicentre trial (the 'Ketzerei' trial)Christian Strauß, Mahan Sadjadi, Thilo von Groote, et al.
Critical Care Medicine|March 28, 2023
The Role of Cell Cycle Arrest Biomarkers for Predicting Acute Kidney Injury in Critically Ill COVID-19 Patients: A Multicenter, Observational StudyRaphael Weiss, Thilo von Groote, Marlies Ostermann, et al.
Lancet (London, England)|November 16, 2025
A preventive care strategy to reduce moderate or severe acute kidney injury after major surgery (BigpAK-2); a multinational, randomised clinical trialAlexander Zarbock, Marlies Ostermann, Lui Forni, et al.
BMJ Open|March 27, 2023
Biomarker-guided intervention to prevent acute kidney injury after major surgery (BigpAK-2 trial): study protocol for an international, prospective, randomised controlled multicentre trialThilo von Groote, Melanie Meersch, Stefano Romagnoli, et al.
Pageof 4